Yep I tend to agree. Odds are against burette making any meaningful contribution to revenue line. Hope I'm wrong but judging by the content of the preso...well... It's not hard to make a case the company is of the same view. Product itself looks ok, but when you're late to market and don't have a strong distribution capability then the task is massive.
That leaves PeriCoach and an equity raising.
Worth keeping an eye on but could be some time 'til any $$$ hit the coffers, which is not unusual for med device companies.
Hold for now but worth keeping close eye on PeriCoach development.
Add to My Watchlist
What is My Watchlist?